JavaScript is off. Please enable to view full site.

AstraZeneca says its vaccine should be effective against new coronavirus variant

AstraZeneca says its vaccine should be effective against new coronavirus variant

Wednesday, December 23, 2020, 08:57 GMT+7
AstraZeneca says its vaccine should be effective against new coronavirus variant
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed AstraZeneca logo in this illustration taken October 31, 2020. Photo: Reuters

British drugmaker AstraZeneca Plc told Reuters on Tuesday its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.

“AZD1222 (AstraZeneca’s vaccine candidate) contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein,” an AstraZeneca representative said in an email.

Drugmakers are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain, the latest challenge in the breakneck race to curb the pandemic.

“Through vaccination with AZD1222, the body’s immune system is trained to recognise many different parts of the spike protein, so that it can eliminate the virus if it is later exposed,” the AstraZeneca representative added.

The mutation known as the B.1.1.7 lineage may be up to 70% more infectious and more of a concern for children.

It has sown chaos in Britain, prompting a wave of travel bans that are disrupting trade with Europe and threatening to further isolate the island country.

The AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates because it is cheaper, easier to transport and can be stored for long periods at normal refrigerator temperatures.

Data from AstraZeneca’s late-stage trials in the UK and Brazil released earlier this month showed the vaccine had efficacy of 62% for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose.

Reuters reported late on Tuesday that India is likely to approve AstraZeneca’s vaccine for emergency use by next week.

Reuters

More

Read more

India bans many single-use plastics to tackle waste

India imposed a ban on many single-use plastics on Friday in a bid to tackle waste choking rivers and poisoning wildlife, but experts say it faces severe headwinds from unprepared manufacturers and consumers unwilling to pay more

10 hours ago
;

Photos

VIDEOS

‘Taste of Australia’ gala dinner held in Ho Chi Minh City after 2-year hiatus

Taste of Australia Gala Reception has returned to the Park Hyatt Hotel in Ho Chi Minh City's District 1 after a two-year hiatus due to the COVID-19 pandemic

Vietnamese woman gives unconditional love to hundreds of adopted children

Despite her own immense hardship, she has taken in and cared for hundreds of orphans over the past three decades.

Vietnam’s Mekong Delta celebrates spring with ‘hat boi’ performances

The art form is so popular that it attracts people from all ages in the Mekong Delta

Vietnamese youngster travels back in time with clay miniatures

Each work is a scene caught by Dung and kept in his memories through his journeys across Vietnam

Latest news

India bans many single-use plastics to tackle waste

India imposed a ban on many single-use plastics on Friday in a bid to tackle waste choking rivers and poisoning wildlife, but experts say it faces severe headwinds from unprepared manufacturers and consumers unwilling to pay more